Home / Gliclazide / Czechia
CZ ATC A10BB09 · updated 2 Nov 2026
Gliclazide shortage in Czechia
Is there a Gliclazide shortage in Czechia?
Yes. As of 2 Nov 2026, 1 Gliclazide product is reported short in Czechia, the first since 14 Sep 2026. The company estimate for the return is 28 Feb 2027. Main reason: manufacturing problem.
Also short in Canada, Italy, Spain, Ireland, Austria, Belgium, Australia. All countries.
Affected products in Czechia
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CZ | GLIKLAZID ACTAVIS 30MG 30MG TBL MRL 90 II | Teva | 14 Sep 2026 | 28 Feb 2027 | Manufacturing problem Výrobní důvody |
Source
SÚKL (State Institute for Drug Control), market reports. Official list. Products whose latest market report is a supply interruption; one row per SÚKL code.